

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.45620440 |
| 2 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.14398130 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.09233542 |
| 4 | gamma-aminobutyric acid transport (GO:0015812) | 4.05367558 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.02163041 |
| 6 | protein maturation by protein folding (GO:0022417) | 3.93821348 |
| 7 | neuronal action potential propagation (GO:0019227) | 3.85119554 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.81431072 |
| 9 | maturation of 5.8S rRNA (GO:0000460) | 3.78630448 |
| 10 | nucleobase catabolic process (GO:0046113) | 3.77668759 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 3.69040437 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.64276162 |
| 13 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.63563993 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.62832400 |
| 15 | synaptic vesicle maturation (GO:0016188) | 3.61226623 |
| 16 | organelle transport along microtubule (GO:0072384) | 3.58313227 |
| 17 | melanosome localization (GO:0032400) | 3.57613936 |
| 18 | protein K11-linked deubiquitination (GO:0035871) | 3.57404140 |
| 19 | establishment of mitochondrion localization (GO:0051654) | 3.55640819 |
| 20 | detection of calcium ion (GO:0005513) | 3.53045840 |
| 21 | glycerophospholipid catabolic process (GO:0046475) | 3.47004688 |
| 22 | glutamate secretion (GO:0014047) | 3.46778269 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 3.46635271 |
| 24 | signal peptide processing (GO:0006465) | 3.45952929 |
| 25 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.45225501 |
| 26 | vesicle docking (GO:0048278) | 3.41868005 |
| 27 | pigment granule localization (GO:0051875) | 3.39623739 |
| 28 | neuron cell-cell adhesion (GO:0007158) | 3.39235810 |
| 29 | adaptation of signaling pathway (GO:0023058) | 3.32193017 |
| 30 | positive regulation of vesicle fusion (GO:0031340) | 3.28993104 |
| 31 | protein import into peroxisome matrix (GO:0016558) | 3.28907684 |
| 32 | presynaptic membrane assembly (GO:0097105) | 3.25238253 |
| 33 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23039476 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.21774688 |
| 35 | nucleotide transmembrane transport (GO:1901679) | 3.21553703 |
| 36 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.20639569 |
| 37 | presynaptic membrane organization (GO:0097090) | 3.20236679 |
| 38 | vesicle docking involved in exocytosis (GO:0006904) | 3.19640897 |
| 39 | tachykinin receptor signaling pathway (GO:0007217) | 3.18827891 |
| 40 | membrane docking (GO:0022406) | 3.18440308 |
| 41 | C4-dicarboxylate transport (GO:0015740) | 3.18128628 |
| 42 | negative regulation of protein oligomerization (GO:0032460) | 3.17157800 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10016171 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 3.09936504 |
| 45 | COPI coating of Golgi vesicle (GO:0048205) | 3.09936504 |
| 46 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.08793372 |
| 47 | regulation of vesicle fusion (GO:0031338) | 3.04228202 |
| 48 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.01266732 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.01165981 |
| 50 | protein-cofactor linkage (GO:0018065) | 3.00672987 |
| 51 | neurofilament cytoskeleton organization (GO:0060052) | 2.99846259 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.99157183 |
| 53 | response to histamine (GO:0034776) | 2.98366256 |
| 54 | microtubule anchoring (GO:0034453) | 2.95974879 |
| 55 | proline transport (GO:0015824) | 2.94712636 |
| 56 | neural tube formation (GO:0001841) | 2.94166552 |
| 57 | magnesium ion transport (GO:0015693) | 2.93554128 |
| 58 | protein retention in ER lumen (GO:0006621) | 2.92287275 |
| 59 | regulation of feeding behavior (GO:0060259) | 2.92213385 |
| 60 | neurotransmitter secretion (GO:0007269) | 2.91597861 |
| 61 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.88387776 |
| 62 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.88387776 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.87368492 |
| 64 | protein localization to synapse (GO:0035418) | 2.85146181 |
| 65 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.83064366 |
| 66 | protein targeting to lysosome (GO:0006622) | 2.82947482 |
| 67 | establishment of protein localization to vacuole (GO:0072666) | 2.82947482 |
| 68 | protein targeting to vacuole (GO:0006623) | 2.82947482 |
| 69 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.80803417 |
| 70 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.80709624 |
| 71 | cellular zinc ion homeostasis (GO:0006882) | 2.79820106 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 2.79268479 |
| 73 | zinc ion homeostasis (GO:0055069) | 2.79268192 |
| 74 | vesicle localization (GO:0051648) | 2.78983430 |
| 75 | ER overload response (GO:0006983) | 2.78258284 |
| 76 | DNA double-strand break processing (GO:0000729) | 2.77881422 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.77845262 |
| 78 | regulation of oxidative phosphorylation (GO:0002082) | 2.77738620 |
| 79 | insulin secretion (GO:0030073) | 2.75974435 |
| 80 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.75814229 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.75360687 |
| 82 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75098194 |
| 83 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75098194 |
| 84 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.73876648 |
| 85 | negative regulation of cation channel activity (GO:2001258) | 2.73860759 |
| 86 | lysosome localization (GO:0032418) | 2.73593628 |
| 87 | regulation of meiosis I (GO:0060631) | 2.73458391 |
| 88 | regulation of synapse structural plasticity (GO:0051823) | 2.71335441 |
| 89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71323427 |
| 90 | establishment of melanosome localization (GO:0032401) | 2.69640189 |
| 91 | regulation of energy homeostasis (GO:2000505) | 2.69291648 |
| 92 | respiratory electron transport chain (GO:0022904) | 2.66610910 |
| 93 | electron transport chain (GO:0022900) | 2.65373130 |
| 94 | actin filament depolymerization (GO:0030042) | 2.65252181 |
| 95 | mitochondrion transport along microtubule (GO:0047497) | 2.64341834 |
| 96 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.64341834 |
| 97 | glutamate receptor signaling pathway (GO:0007215) | 2.64077753 |
| 98 | peptide hormone processing (GO:0016486) | 2.64046688 |
| 99 | glycosphingolipid biosynthetic process (GO:0006688) | 2.64022303 |
| 100 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.63745537 |
| 101 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.63745537 |
| 102 | regulation of cofactor metabolic process (GO:0051193) | 2.63562057 |
| 103 | regulation of coenzyme metabolic process (GO:0051196) | 2.63562057 |
| 104 | transferrin transport (GO:0033572) | 2.62098598 |
| 105 | dopamine biosynthetic process (GO:0042416) | 2.61423773 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.61351695 |
| 107 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.61286275 |
| 108 | neuron-neuron synaptic transmission (GO:0007270) | 2.60958229 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 2.60898163 |
| 110 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60653891 |
| 111 | synapse assembly (GO:0007416) | 2.60223632 |
| 112 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.60070915 |
| 113 | positive regulation of dendritic spine development (GO:0060999) | 2.59678226 |
| 114 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.59622899 |
| 115 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.59043770 |
| 116 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.59043770 |
| 117 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.58991449 |
| 118 | vocalization behavior (GO:0071625) | 2.58214320 |
| 119 | protein targeting to peroxisome (GO:0006625) | 2.58138923 |
| 120 | establishment of protein localization to peroxisome (GO:0072663) | 2.58138923 |
| 121 | protein localization to peroxisome (GO:0072662) | 2.58138923 |
| 122 | positive regulation of amino acid transport (GO:0051957) | 2.57899802 |
| 123 | establishment of protein localization to Golgi (GO:0072600) | 2.57659732 |
| 124 | vesicle transport along microtubule (GO:0047496) | 2.54214358 |
| 125 | microtubule-based transport (GO:0010970) | 2.54196718 |
| 126 | establishment of pigment granule localization (GO:0051905) | 2.53910572 |
| 127 | synaptic transmission, dopaminergic (GO:0001963) | 2.53602827 |
| 128 | positive regulation of insulin secretion (GO:0032024) | 2.53174679 |
| 129 | prepulse inhibition (GO:0060134) | 2.53106087 |
| 130 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.52543644 |
| 131 | protein targeting to Golgi (GO:0000042) | 2.51706672 |
| 132 | innervation (GO:0060384) | 2.51348958 |
| 133 | ferric iron transport (GO:0015682) | 2.50988626 |
| 134 | trivalent inorganic cation transport (GO:0072512) | 2.50988626 |
| 135 | activation of protein kinase A activity (GO:0034199) | 2.50655628 |
| 136 | negative regulation of neurotransmitter transport (GO:0051589) | 2.50547857 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.49733265 |
| 138 | transmission of nerve impulse (GO:0019226) | 2.49273717 |
| 139 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.49127589 |
| 140 | ATP synthesis coupled proton transport (GO:0015986) | 2.49127589 |
| 141 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.49052570 |
| 142 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.48329618 |
| 143 | regulation of dendritic spine development (GO:0060998) | 2.48270462 |
| 144 | positive regulation of exocytosis (GO:0045921) | 2.47705687 |
| 145 | regulation of amino acid transport (GO:0051955) | 2.47307906 |
| 146 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.47107036 |
| 147 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.46882263 |
| 148 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.46835472 |
| 149 | postsynaptic membrane organization (GO:0001941) | 2.45585638 |
| 150 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.45349318 |
| 151 | regulation of neurotransmitter secretion (GO:0046928) | 2.43938980 |
| 152 | protein localization to cilium (GO:0061512) | 2.43937253 |
| 153 | oligosaccharide biosynthetic process (GO:0009312) | 2.43918430 |
| 154 | regulation of insulin secretion (GO:0050796) | 2.43780695 |
| 155 | inner mitochondrial membrane organization (GO:0007007) | 2.43184458 |
| 156 | cellular response to glucagon stimulus (GO:0071377) | 2.41649901 |
| 157 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.40056300 |
| 158 | regulation of glutamate secretion (GO:0014048) | 2.39854278 |
| 159 | synaptic transmission, glutamatergic (GO:0035249) | 2.39755564 |
| 160 | positive regulation of neurotransmitter transport (GO:0051590) | 2.39246145 |
| 161 | protein complex biogenesis (GO:0070271) | 2.39180572 |
| 162 | melanosome transport (GO:0032402) | 2.39119849 |
| 163 | regulation of neuron projection regeneration (GO:0070570) | 2.38869945 |
| 164 | regulation of axon regeneration (GO:0048679) | 2.38869945 |
| 165 | neurotransmitter transport (GO:0006836) | 2.38657790 |
| 166 | regulation of protein kinase A signaling (GO:0010738) | 2.38207705 |
| 167 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.38146336 |
| 168 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.36716548 |
| 169 | signal release (GO:0023061) | 2.35204357 |
| 170 | response to amphetamine (GO:0001975) | 2.35132068 |
| 171 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.33946611 |
| 172 | serotonin receptor signaling pathway (GO:0007210) | 2.32702864 |
| 173 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.32565963 |
| 174 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.32488239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.41092519 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.04860905 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.83458653 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.81284615 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.74655727 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.66580527 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64118833 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57746933 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55300880 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46472607 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.36092351 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35041374 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33167158 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27882101 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.26353928 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25369480 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22560227 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20426487 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20109785 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18970774 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12897197 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.09699822 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05653412 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03153561 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03153561 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95382357 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.94940850 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94086250 |
| 29 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.92220389 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89577797 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.88665258 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84527781 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84178052 |
| 34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.83160632 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79953356 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78088954 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77137371 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76286530 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74768823 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74434005 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73812746 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.72993346 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70740465 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69688671 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62223779 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61585736 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57900716 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55389901 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54587931 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50711631 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45876001 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45132258 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42661683 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40682636 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40679583 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39515248 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38564387 |
| 58 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37745124 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37507483 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37310930 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36934210 |
| 62 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36760019 |
| 63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32394177 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32078008 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28751771 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28579545 |
| 67 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26635115 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25409209 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25245957 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24791329 |
| 71 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23847103 |
| 72 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23776936 |
| 73 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.23173551 |
| 74 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.21597593 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21184198 |
| 76 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19904014 |
| 77 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19451198 |
| 78 | JUN_21703547_ChIP-Seq_K562_Human | 1.18794269 |
| 79 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.18624717 |
| 80 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.18477249 |
| 81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18025628 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16240503 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14411228 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13824772 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13674699 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13503497 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13227561 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11015867 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11015867 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10839506 |
| 91 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09082788 |
| 92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08995961 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08836520 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08780122 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08107080 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07693102 |
| 97 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.07597141 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06041062 |
| 99 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06022273 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.06005337 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05676505 |
| 102 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04838168 |
| 103 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04546756 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03400540 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02744397 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02669652 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02022199 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00735708 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99955049 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99955049 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98055025 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97610425 |
| 113 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97110009 |
| 114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96420872 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95025832 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94880663 |
| 117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94667146 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93188033 |
| 119 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92726998 |
| 120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92726998 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92375259 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90204468 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89773337 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89342888 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.89302628 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88985397 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87473791 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87338432 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84814243 |
| 130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84673842 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82369277 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80921429 |
| 133 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80005157 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79549412 |
| 135 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79325877 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79111669 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78282581 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.77865833 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.77743907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.98757330 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.27822705 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.16915689 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.04844419 |
| 5 | MP0010386_abnormal_urinary_bladder | 2.88778806 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.84911805 |
| 7 | MP0002909_abnormal_adrenal_gland | 2.80979639 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.78741295 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.75456908 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.74125724 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.67769583 |
| 12 | MP0004270_analgesia | 2.64212496 |
| 13 | MP0003787_abnormal_imprinting | 2.52943835 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.45840322 |
| 15 | MP0002254_reproductive_system_inflammat | 2.43823371 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.35718281 |
| 17 | MP0009745_abnormal_behavioral_response | 2.34212945 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.29821564 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.26470798 |
| 20 | MP0009046_muscle_twitch | 2.24283236 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.20620723 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.17400815 |
| 23 | MP0002736_abnormal_nociception_after | 2.17201740 |
| 24 | MP0001984_abnormal_olfaction | 2.17154097 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.16778837 |
| 26 | MP0004147_increased_porphyrin_level | 2.13499988 |
| 27 | MP0002064_seizures | 2.09987935 |
| 28 | MP0001970_abnormal_pain_threshold | 2.09628692 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 2.08022329 |
| 30 | MP0002876_abnormal_thyroid_physiology | 2.03551679 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.99212130 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.97744623 |
| 33 | MP0002272_abnormal_nervous_system | 1.90029243 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.88261298 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.86546149 |
| 36 | MP0003121_genomic_imprinting | 1.81940205 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.79117827 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.78850694 |
| 39 | MP0003890_abnormal_embryonic-extraembry | 1.75732450 |
| 40 | MP0003195_calcinosis | 1.75685004 |
| 41 | MP0004885_abnormal_endolymph | 1.73002525 |
| 42 | MP0002163_abnormal_gland_morphology | 1.65144515 |
| 43 | MP0005535_abnormal_body_temperature | 1.63354906 |
| 44 | MP0003122_maternal_imprinting | 1.62738331 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.58686264 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.56697014 |
| 47 | MP0001905_abnormal_dopamine_level | 1.56594049 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.51023226 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.50763418 |
| 50 | MP0004043_abnormal_pH_regulation | 1.50466801 |
| 51 | MP0002184_abnormal_innervation | 1.48239780 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.47931664 |
| 53 | MP0004924_abnormal_behavior | 1.38453929 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.38453929 |
| 55 | MP0005408_hypopigmentation | 1.37572611 |
| 56 | MP0000778_abnormal_nervous_system | 1.35828508 |
| 57 | MP0006082_CNS_inflammation | 1.34184094 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.33976225 |
| 59 | MP0001486_abnormal_startle_reflex | 1.32973090 |
| 60 | MP0001188_hyperpigmentation | 1.31850785 |
| 61 | MP0003329_amyloid_beta_deposits | 1.27261308 |
| 62 | MP0003879_abnormal_hair_cell | 1.24805086 |
| 63 | MP0002822_catalepsy | 1.24323837 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.23486823 |
| 65 | MP0005187_abnormal_penis_morphology | 1.22056031 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 1.19381243 |
| 67 | MP0000372_irregular_coat_pigmentation | 1.16132547 |
| 68 | MP0001529_abnormal_vocalization | 1.14225058 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.13683224 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.12881434 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 1.12408525 |
| 72 | MP0002229_neurodegeneration | 1.12174435 |
| 73 | MP0004858_abnormal_nervous_system | 1.11479762 |
| 74 | MP0003690_abnormal_glial_cell | 1.10248469 |
| 75 | MP0004742_abnormal_vestibular_system | 1.09791496 |
| 76 | MP0003283_abnormal_digestive_organ | 1.07724772 |
| 77 | MP0008569_lethality_at_weaning | 1.05568608 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.05545358 |
| 79 | MP0000538_abnormal_urinary_bladder | 1.04114891 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.03933511 |
| 81 | MP0005253_abnormal_eye_physiology | 1.01669379 |
| 82 | MP0004142_abnormal_muscle_tone | 1.01556010 |
| 83 | MP0005499_abnormal_olfactory_system | 1.00662429 |
| 84 | MP0005394_taste/olfaction_phenotype | 1.00662429 |
| 85 | MP0004484_altered_response_of | 1.00606241 |
| 86 | MP0000230_abnormal_systemic_arterial | 1.00436349 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.99946162 |
| 88 | MP0000681_abnormal_thyroid_gland | 0.99371721 |
| 89 | MP0001919_abnormal_reproductive_system | 0.98120646 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.97278798 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.96509395 |
| 92 | MP0003633_abnormal_nervous_system | 0.95285763 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.94021995 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.93490937 |
| 95 | MP0005389_reproductive_system_phenotype | 0.93255593 |
| 96 | MP0004811_abnormal_neuron_physiology | 0.93146234 |
| 97 | MP0001664_abnormal_digestion | 0.92277034 |
| 98 | MP0002090_abnormal_vision | 0.92136397 |
| 99 | MP0006292_abnormal_olfactory_placode | 0.91681057 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.91410702 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.90069190 |
| 102 | MP0002102_abnormal_ear_morphology | 0.88126847 |
| 103 | MP0001177_atelectasis | 0.88008006 |
| 104 | MP0002160_abnormal_reproductive_system | 0.87963327 |
| 105 | MP0004145_abnormal_muscle_electrophysio | 0.87608890 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.87181331 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.85594835 |
| 108 | MP0003631_nervous_system_phenotype | 0.85511896 |
| 109 | MP0009697_abnormal_copulation | 0.85394933 |
| 110 | MP0005448_abnormal_energy_balance | 0.84910142 |
| 111 | MP0004510_myositis | 0.84175278 |
| 112 | MP0003698_abnormal_male_reproductive | 0.83880316 |
| 113 | MP0008872_abnormal_physiological_respon | 0.83641052 |
| 114 | MP0003646_muscle_fatigue | 0.83316849 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.83018302 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.82996026 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.82885769 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.82834429 |
| 119 | MP0008995_early_reproductive_senescence | 0.82199184 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.80833363 |
| 121 | MP0002132_abnormal_respiratory_system | 0.80735705 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.79892160 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.79540201 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79122592 |
| 125 | MP0002234_abnormal_pharynx_morphology | 0.78691717 |
| 126 | MP0001270_distended_abdomen | 0.78533810 |
| 127 | MP0003953_abnormal_hormone_level | 0.76864213 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.76123183 |
| 129 | MP0004130_abnormal_muscle_cell | 0.74972146 |
| 130 | MP0003724_increased_susceptibility_to | 0.73859198 |
| 131 | MP0000955_abnormal_spinal_cord | 0.71807386 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.70998646 |
| 133 | MP0002882_abnormal_neuron_morphology | 0.70280524 |
| 134 | MP0003959_abnormal_lean_body | 0.70031237 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.69361057 |
| 136 | MP0004085_abnormal_heartbeat | 0.67742622 |
| 137 | MP0005423_abnormal_somatic_nervous | 0.67059523 |
| 138 | MP0001756_abnormal_urination | 0.66803014 |
| 139 | MP0000604_amyloidosis | 0.64769088 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.59599630 |
| 141 | MP0008874_decreased_physiological_sensi | 0.59588884 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.59518624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.55105674 |
| 2 | Hypothermia (HP:0002045) | 4.41918964 |
| 3 | Visual hallucinations (HP:0002367) | 3.85877985 |
| 4 | Atonic seizures (HP:0010819) | 3.66456547 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.63977515 |
| 6 | Papilledema (HP:0001085) | 3.44795316 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.39428587 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.36519466 |
| 9 | Agitation (HP:0000713) | 3.33245568 |
| 10 | Epileptic encephalopathy (HP:0200134) | 3.31909817 |
| 11 | Pheochromocytoma (HP:0002666) | 3.26379411 |
| 12 | Hip dysplasia (HP:0001385) | 3.25844204 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.15859396 |
| 14 | Abnormality of B cell number (HP:0010975) | 3.14888228 |
| 15 | Oligodactyly (hands) (HP:0001180) | 3.13381379 |
| 16 | Absence seizures (HP:0002121) | 3.07992758 |
| 17 | Myokymia (HP:0002411) | 3.00561410 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 3.00445260 |
| 19 | Fibular aplasia (HP:0002990) | 2.99112577 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.97858736 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.97858736 |
| 22 | Focal seizures (HP:0007359) | 2.92287561 |
| 23 | Limb dystonia (HP:0002451) | 2.91540257 |
| 24 | Progressive macrocephaly (HP:0004481) | 2.91503114 |
| 25 | Febrile seizures (HP:0002373) | 2.90690166 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.89324145 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.89324145 |
| 28 | Amyotrophic lateral sclerosis (HP:0007354) | 2.84537782 |
| 29 | Mitochondrial inheritance (HP:0001427) | 2.82293452 |
| 30 | Drooling (HP:0002307) | 2.81986963 |
| 31 | Retinal dysplasia (HP:0007973) | 2.81235493 |
| 32 | Hypoglycemic seizures (HP:0002173) | 2.80259205 |
| 33 | Acute encephalopathy (HP:0006846) | 2.80022366 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.77858605 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.76552224 |
| 36 | Anxiety (HP:0000739) | 2.70693793 |
| 37 | Generalized tonic-clonic seizures (HP:0002069) | 2.70384603 |
| 38 | Oligomenorrhea (HP:0000876) | 2.69335108 |
| 39 | Hyperventilation (HP:0002883) | 2.68571037 |
| 40 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.63241361 |
| 41 | Menstrual irregularities (HP:0000858) | 2.62324973 |
| 42 | Lissencephaly (HP:0001339) | 2.61602860 |
| 43 | Failure to thrive in infancy (HP:0001531) | 2.56013711 |
| 44 | Urinary urgency (HP:0000012) | 2.54585214 |
| 45 | Symptomatic seizures (HP:0011145) | 2.54490740 |
| 46 | Dialeptic seizures (HP:0011146) | 2.52929259 |
| 47 | Excessive salivation (HP:0003781) | 2.52627108 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 2.48432096 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.44031707 |
| 50 | Abnormality of alanine metabolism (HP:0010916) | 2.44031707 |
| 51 | Hyperalaninemia (HP:0003348) | 2.44031707 |
| 52 | Type II lissencephaly (HP:0007260) | 2.42912122 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.42514480 |
| 54 | Absent speech (HP:0001344) | 2.42066493 |
| 55 | Polyphagia (HP:0002591) | 2.37773560 |
| 56 | Hepatic necrosis (HP:0002605) | 2.36808629 |
| 57 | B lymphocytopenia (HP:0010976) | 2.34981762 |
| 58 | Gait imbalance (HP:0002141) | 2.33106139 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.32943803 |
| 60 | Hepatoblastoma (HP:0002884) | 2.31865592 |
| 61 | Increased CSF lactate (HP:0002490) | 2.31146737 |
| 62 | Fair hair (HP:0002286) | 2.31117754 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.31045482 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31045482 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.29009536 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.27888802 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.27840762 |
| 68 | Progressive inability to walk (HP:0002505) | 2.27200345 |
| 69 | Spastic gait (HP:0002064) | 2.26621856 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.25935786 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.21654415 |
| 72 | Split foot (HP:0001839) | 2.20811449 |
| 73 | Hyperthyroidism (HP:0000836) | 2.19850165 |
| 74 | Gonadotropin excess (HP:0000837) | 2.18442212 |
| 75 | Depression (HP:0000716) | 2.17921730 |
| 76 | Thyroid-stimulating hormone excess (HP:0002925) | 2.17735504 |
| 77 | Spastic tetraplegia (HP:0002510) | 2.16953304 |
| 78 | Hypoglycemic coma (HP:0001325) | 2.16210158 |
| 79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15754414 |
| 80 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.15606212 |
| 81 | Autoamputation (HP:0001218) | 2.15481183 |
| 82 | Nephrogenic diabetes insipidus (HP:0009806) | 2.15110747 |
| 83 | Thyroid carcinoma (HP:0002890) | 2.14911509 |
| 84 | Ketoacidosis (HP:0001993) | 2.14362374 |
| 85 | Mutism (HP:0002300) | 2.12877010 |
| 86 | Growth hormone excess (HP:0000845) | 2.12746954 |
| 87 | Central scotoma (HP:0000603) | 2.10871010 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 2.10224957 |
| 89 | Broad-based gait (HP:0002136) | 2.09223919 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.09100339 |
| 91 | Increased muscle lipid content (HP:0009058) | 2.08554067 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08306000 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08306000 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08306000 |
| 95 | Hypercortisolism (HP:0001578) | 2.06787350 |
| 96 | Volvulus (HP:0002580) | 2.05925385 |
| 97 | Short tibia (HP:0005736) | 2.03525533 |
| 98 | Hypoplastic iliac wings (HP:0002866) | 2.03255851 |
| 99 | Amblyopia (HP:0000646) | 2.02644222 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02428288 |
| 101 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.02037608 |
| 102 | Abnormal eating behavior (HP:0100738) | 2.01980903 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01763075 |
| 104 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99360151 |
| 105 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99360151 |
| 106 | Abnormal protein glycosylation (HP:0012346) | 1.99360151 |
| 107 | Abnormal glycosylation (HP:0012345) | 1.99360151 |
| 108 | Abnormality of the vocal cords (HP:0008777) | 1.99295562 |
| 109 | Lower limb muscle weakness (HP:0007340) | 1.98173621 |
| 110 | Dysautonomia (HP:0002459) | 1.94061722 |
| 111 | Inability to walk (HP:0002540) | 1.93676089 |
| 112 | Abnormal hair whorl (HP:0010721) | 1.93160045 |
| 113 | Impaired social interactions (HP:0000735) | 1.93105872 |
| 114 | Abnormal social behavior (HP:0012433) | 1.93105872 |
| 115 | Beaking of vertebral bodies (HP:0004568) | 1.92958450 |
| 116 | Neoplasm of the adrenal gland (HP:0100631) | 1.92859561 |
| 117 | Acanthocytosis (HP:0001927) | 1.92110881 |
| 118 | Truncal ataxia (HP:0002078) | 1.91961429 |
| 119 | Pachygyria (HP:0001302) | 1.91513619 |
| 120 | Type I transferrin isoform profile (HP:0003642) | 1.91332762 |
| 121 | Abnormality of the renal cortex (HP:0011035) | 1.90560377 |
| 122 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89151463 |
| 123 | Cerebral hemorrhage (HP:0001342) | 1.88156588 |
| 124 | Supranuclear gaze palsy (HP:0000605) | 1.87255604 |
| 125 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86799952 |
| 126 | Lactic acidosis (HP:0003128) | 1.86338280 |
| 127 | Adactyly (HP:0009776) | 1.85957635 |
| 128 | Muscular hypotonia of the trunk (HP:0008936) | 1.85726364 |
| 129 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85687702 |
| 130 | Restlessness (HP:0000711) | 1.85311946 |
| 131 | Generalized hypopigmentation of hair (HP:0011358) | 1.85267934 |
| 132 | Hypsarrhythmia (HP:0002521) | 1.84539702 |
| 133 | Paraplegia (HP:0010550) | 1.84203230 |
| 134 | Decreased muscle mass (HP:0003199) | 1.83680853 |
| 135 | Thoracolumbar scoliosis (HP:0002944) | 1.82710789 |
| 136 | Cerebral hypomyelination (HP:0006808) | 1.79597414 |
| 137 | Protruding tongue (HP:0010808) | 1.79491414 |
| 138 | Poor suck (HP:0002033) | 1.79288124 |
| 139 | Short foot (HP:0001773) | 1.78767910 |
| 140 | Oligodactyly (HP:0012165) | 1.78639145 |
| 141 | Gaze-evoked nystagmus (HP:0000640) | 1.78352731 |
| 142 | Impaired vibratory sensation (HP:0002495) | 1.78007110 |
| 143 | Arthropathy (HP:0003040) | 1.77552598 |
| 144 | Termporal pattern (HP:0011008) | 1.75936494 |
| 145 | Insidious onset (HP:0003587) | 1.75936494 |
| 146 | Broad alveolar ridges (HP:0000187) | 1.75913911 |
| 147 | Intention tremor (HP:0002080) | 1.75455334 |
| 148 | Ankle clonus (HP:0011448) | 1.75058879 |
| 149 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74989614 |
| 150 | Action tremor (HP:0002345) | 1.74723531 |
| 151 | Abnormality of the lower motor neuron (HP:0002366) | 1.74308474 |
| 152 | CNS demyelination (HP:0007305) | 1.73965048 |
| 153 | Renal cortical cysts (HP:0000803) | 1.73869908 |
| 154 | Tubulointerstitial nephritis (HP:0001970) | 1.73111778 |
| 155 | Delusions (HP:0000746) | 1.72968473 |
| 156 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.72777160 |
| 157 | Abnormality of macular pigmentation (HP:0008002) | 1.72213340 |
| 158 | CNS hypomyelination (HP:0003429) | 1.72075842 |
| 159 | Optic disc pallor (HP:0000543) | 1.71869128 |
| 160 | Exercise intolerance (HP:0003546) | 1.70842598 |
| 161 | Poor eye contact (HP:0000817) | 1.70122648 |
| 162 | Palpitations (HP:0001962) | 1.69627303 |
| 163 | Hyperactive renin-angiotensin system (HP:0000841) | 1.69611733 |
| 164 | Psychosis (HP:0000709) | 1.68470777 |
| 165 | X-linked dominant inheritance (HP:0001423) | 1.67999363 |
| 166 | Hypokinesia (HP:0002375) | 1.67652796 |
| 167 | Brushfield spots (HP:0001088) | 1.66813933 |
| 168 | Testicular neoplasm (HP:0010788) | 1.66586369 |
| 169 | Focal dystonia (HP:0004373) | 1.66019400 |
| 170 | Abnormality of binocular vision (HP:0011514) | 1.65004043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.00969545 |
| 2 | NTRK3 | 3.57177760 |
| 3 | BCR | 3.21087626 |
| 4 | RIPK4 | 3.15569905 |
| 5 | MAP4K2 | 3.01491799 |
| 6 | TRIM28 | 2.54501342 |
| 7 | MAP2K7 | 2.42886898 |
| 8 | ARAF | 2.40636069 |
| 9 | CAMKK2 | 2.37146471 |
| 10 | WNK3 | 2.20659071 |
| 11 | CSNK1G1 | 2.19838991 |
| 12 | MINK1 | 2.15005042 |
| 13 | MAP3K13 | 2.06657524 |
| 14 | CASK | 2.02391803 |
| 15 | INSRR | 2.01097175 |
| 16 | CSNK1G2 | 1.98300140 |
| 17 | MAP3K2 | 1.97207840 |
| 18 | SIK3 | 1.96503543 |
| 19 | MAP3K9 | 1.95166286 |
| 20 | FRK | 1.88190283 |
| 21 | GRK5 | 1.86492572 |
| 22 | MAP3K4 | 1.79889066 |
| 23 | CSNK1A1L | 1.79043671 |
| 24 | CSNK1G3 | 1.78489420 |
| 25 | BMPR2 | 1.76301122 |
| 26 | MAP2K4 | 1.74288305 |
| 27 | EPHA4 | 1.62408838 |
| 28 | NME1 | 1.59273575 |
| 29 | NTRK1 | 1.57555227 |
| 30 | KSR2 | 1.49077154 |
| 31 | BMPR1B | 1.34071970 |
| 32 | MAP3K3 | 1.30229675 |
| 33 | PLK2 | 1.29873015 |
| 34 | TAOK2 | 1.25805203 |
| 35 | STK39 | 1.24080260 |
| 36 | LATS1 | 1.23304317 |
| 37 | TNIK | 1.23073178 |
| 38 | SCYL2 | 1.21840611 |
| 39 | ACVR1B | 1.21815251 |
| 40 | ERBB3 | 1.20425678 |
| 41 | BLK | 1.20337780 |
| 42 | DAPK2 | 1.18758923 |
| 43 | SIK2 | 1.18721923 |
| 44 | DAPK1 | 1.17306633 |
| 45 | MAP3K11 | 1.15071267 |
| 46 | PIM2 | 1.13254326 |
| 47 | NUAK1 | 1.13184561 |
| 48 | AKT3 | 1.07234543 |
| 49 | MAP3K1 | 1.06672419 |
| 50 | MAPK15 | 1.05509060 |
| 51 | PTK2B | 1.05368586 |
| 52 | EPHA3 | 1.05265224 |
| 53 | CDK5 | 1.03773239 |
| 54 | GRK7 | 1.02056537 |
| 55 | MUSK | 1.01818657 |
| 56 | ADRBK2 | 1.00822484 |
| 57 | HIPK2 | 0.98937635 |
| 58 | MAPK13 | 0.97280618 |
| 59 | MARK1 | 0.95405729 |
| 60 | CAMKK1 | 0.94683129 |
| 61 | OXSR1 | 0.93835169 |
| 62 | PRKCE | 0.93817656 |
| 63 | STK38L | 0.93347903 |
| 64 | EIF2AK1 | 0.92428874 |
| 65 | PRPF4B | 0.91129754 |
| 66 | CDK19 | 0.89637957 |
| 67 | PAK3 | 0.88188134 |
| 68 | NME2 | 0.87202387 |
| 69 | DYRK3 | 0.85313806 |
| 70 | BRAF | 0.85305298 |
| 71 | RAF1 | 0.85111657 |
| 72 | CAMK2A | 0.84445908 |
| 73 | PRKCI | 0.82105009 |
| 74 | KIT | 0.82071478 |
| 75 | SGK2 | 0.81329775 |
| 76 | SYK | 0.80206711 |
| 77 | PAK6 | 0.79392047 |
| 78 | MAP2K1 | 0.78924195 |
| 79 | ERN1 | 0.76297281 |
| 80 | PRKCG | 0.75042466 |
| 81 | PRKG2 | 0.73524870 |
| 82 | MYLK | 0.72942062 |
| 83 | MAP3K5 | 0.71360373 |
| 84 | KSR1 | 0.70314508 |
| 85 | MAPKAPK5 | 0.69997964 |
| 86 | BCKDK | 0.69642943 |
| 87 | SGK3 | 0.69415570 |
| 88 | PINK1 | 0.69373748 |
| 89 | UHMK1 | 0.68716104 |
| 90 | FES | 0.68544055 |
| 91 | CCNB1 | 0.68030433 |
| 92 | IRAK2 | 0.67021264 |
| 93 | NLK | 0.66163706 |
| 94 | PRKD3 | 0.66111155 |
| 95 | GRK1 | 0.65563476 |
| 96 | FGFR1 | 0.65407394 |
| 97 | FER | 0.65401269 |
| 98 | IRAK1 | 0.65157862 |
| 99 | ADRBK1 | 0.65100620 |
| 100 | MAP3K6 | 0.63943868 |
| 101 | PRKCH | 0.62383821 |
| 102 | CDK8 | 0.62334256 |
| 103 | TNK2 | 0.61404526 |
| 104 | FLT3 | 0.61234714 |
| 105 | PIK3CA | 0.59716176 |
| 106 | MAPKAPK3 | 0.57114779 |
| 107 | DYRK2 | 0.56871472 |
| 108 | CAMK1 | 0.54730426 |
| 109 | DYRK1A | 0.54553017 |
| 110 | PHKG1 | 0.53453726 |
| 111 | PHKG2 | 0.53453726 |
| 112 | TEC | 0.53351645 |
| 113 | LATS2 | 0.52785647 |
| 114 | BRD4 | 0.52208127 |
| 115 | PASK | 0.49411853 |
| 116 | CSNK1D | 0.48157311 |
| 117 | CAMK2D | 0.48101153 |
| 118 | RPS6KA4 | 0.47676635 |
| 119 | MKNK2 | 0.47667457 |
| 120 | LIMK1 | 0.47533799 |
| 121 | CAMK2B | 0.47219451 |
| 122 | PRKCZ | 0.47006946 |
| 123 | SGK1 | 0.46980747 |
| 124 | PRKD2 | 0.46419638 |
| 125 | CDK14 | 0.45400594 |
| 126 | DYRK1B | 0.45337432 |
| 127 | CSNK1E | 0.45182643 |
| 128 | FGFR3 | 0.44990928 |
| 129 | WNK4 | 0.44946629 |
| 130 | RET | 0.44687836 |
| 131 | CSNK1A1 | 0.43815781 |
| 132 | PRKACA | 0.42905147 |
| 133 | SGK223 | 0.42762785 |
| 134 | SGK494 | 0.42762785 |
| 135 | SRPK1 | 0.42294119 |
| 136 | FGR | 0.41560207 |
| 137 | EIF2AK3 | 0.41554179 |
| 138 | NTRK2 | 0.40725338 |
| 139 | RPS6KA2 | 0.40320316 |
| 140 | JAK3 | 0.39302578 |
| 141 | TAOK3 | 0.39205593 |
| 142 | TIE1 | 0.38674547 |
| 143 | MOS | 0.37251125 |
| 144 | MAP2K6 | 0.36169475 |
| 145 | CAMK4 | 0.34358553 |
| 146 | CDK18 | 0.34019948 |
| 147 | STK3 | 0.33720365 |
| 148 | WNK1 | 0.33150728 |
| 149 | PRKG1 | 0.33086772 |
| 150 | FGFR2 | 0.32131992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.29897816 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.05179241 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.89788531 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66047949 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25267851 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24662913 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.23639745 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.20766551 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19822926 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.18939144 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.16674516 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.10737383 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08772629 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.08646051 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04902911 |
| 16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.02530465 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99270340 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91619454 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.89572694 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.81264760 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.80955949 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.80917946 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80122094 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78255144 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71335610 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71070036 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70865926 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70403542 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.63457498 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61202155 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58441321 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56998040 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.52134659 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44402736 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42146961 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41120353 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39516631 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.35918065 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34994500 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34610313 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34006878 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33470942 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.32431678 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29631986 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25270611 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23418849 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.23131903 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22098422 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19750829 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17853781 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16299734 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12126204 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09616096 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08271123 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08001255 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05473245 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01508898 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99328576 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97414185 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95150966 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.94507146 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.93898217 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92807012 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91686062 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90100147 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 0.87517276 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86333623 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.85830560 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85555248 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85072687 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84830418 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82524040 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82171938 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81095725 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80068783 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79190540 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79168636 |
| 78 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77074645 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.76655187 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.75239504 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.75130744 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73377868 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73333499 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72988417 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71937422 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71656392 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70069266 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.69779185 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69627237 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67050447 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66810143 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62563902 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61904806 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61282258 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59680884 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58090652 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57947413 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57236725 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55863617 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55482626 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53618954 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52080770 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51346685 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50553458 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.50453230 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.48849072 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47647533 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46711257 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46038350 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45914874 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45318415 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44971813 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44965896 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44393992 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43916879 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43059536 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.42598040 |
| 118 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39710950 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.38862212 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36898519 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.36502987 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35058813 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32142700 |
| 124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31410185 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30856374 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30640459 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29966625 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.29955582 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29096720 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27664692 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26916356 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26390684 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25492054 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24142831 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23777573 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22906588 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22671162 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21263458 |
| 139 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20928496 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20389735 |
| 141 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.20208169 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19785092 |
| 143 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19733560 |
| 144 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19570405 |
| 145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18262570 |

